Paris, Jan 25, 2026, 18:02 CET — Market closed.
- Barclays bumped L’Oreal to “overweight,” lifting its target price to 435 euros.
- On Friday, L’Oreal shares ended at 386.25 euros, slipping 0.26%, while the CAC 40 dropped 0.07%.
- Traders are eyeing Monday’s open and L’Oreal’s annual results on Feb. 12 as the next key catalyst.
Barclays upgraded L’Oreal (OREP.PA) to “overweight” from “underweight” and pushed its price target to 435 euros, according to a broker note. L’Oreal shares closed Friday at 386.25 euros, down 0.26%, while France’s CAC 40 index dipped 0.07%, per the company’s investor site. The beauty giant is set to release its 2025 annual results on Feb. 12 after markets close. Finanznachrichten Loreal Finance
Timing is key. Investors are positioning themselves ahead of February results, a period when management’s outlook on demand and pricing usually has a bigger impact on shares than daily news.
Paris markets are closed for the weekend, so all eyes turn to Monday’s Euronext open. The key question: will the upgrade spark new buying, or will cautious risk appetite continue to weigh on consumer stocks?
Barclays set a 435-euro target, suggesting about a 13% gain from Friday’s closing price. The bank’s “overweight” rating means it recommends holding more than the benchmark allocation, while “underweight” indicates the opposite.
Barclays analyst Warren Ackerman laid out a fresh framework for European consumer staples, highlighting Unilever and L’Oreal as his top picks. On the flip side, he flagged Essity and Lindt as his least preferred names, according to the note. Ackerman’s 2026 organic growth forecast for L’Oreal also comes in above the market consensus; this measure excludes currency fluctuations and acquisition impacts.
JPMorgan took a more cautious stance. Analyst Celine Pannuti maintained a “neutral” rating on L’Oreal but flagged the stock with a “Positive Catalyst Watch.” She pointed to what she described as mixed signals from Procter & Gamble’s latest report on European consumer groups. Finanznachrichten
Pannuti pointed to Procter & Gamble’s prestige beauty portfolio showing strong results as a bullish sign for L’Oreal, since its Luxe division operates in the same premium segment.
But the setup works both ways. A stronger euro, a slowdown in China, or increased discounting might weigh on volume and margins. Upgrades won’t shield marquee stocks if their results fall short of expectations.
Next week brings the U.S. Federal Reserve’s policy meeting on Jan. 27-28, a key event that could move the dollar and risk appetite. Investors in major international consumer groups are keeping a sharp eye on it. Federalreserve
L’Oreal faces its next major test on Feb. 12, with a financial briefing set for Feb. 13. Investors will dig into regional trends, focusing on the U.S. and China, and seek updates on pricing strategies and product launches heading into 2026.
